Merck (MRK 0.10%), one of the biggest drugmakers on the planet, may not be among the most exciting or innovative health care companies, but it is often favored by long-term investors. In this video, health care analyst Max Macaluso dives into three compelling reasons why investors should think about buying Merck.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.